← Open Payments lookup

GORDON CROFOOT: Open Payments

NPI 1730381005 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,550 in 111 payments from 15 companies in 2025. Trend: 2023 $2,468 · 2024 $1,905 · 2025 $6,550

Consulting: $3,440Food & beverage: $2,647Travel & lodging: $463
CompanyPaymentsAmount
Merck Sharp & Dohme LLC9$4,149
ViiV Healthcare Company42$994
Gilead Sciences, Inc.21$632
Novo Nordisk Inc11$181
Theratechnologies Inc.5$132
Lilly USA, LLC6$125
EMD Serono, Inc.4$101
Napo Pharmaceuticals Inc5$94
Antares Pharma, Inc.2$36
PFIZER INC.1$20

Products named: CABENUVA, PIFELTRO, APRETUDE, RUKOBIA, EGRIFTA, MOUNJARO, Wegovy, Mytesi.

Industry payments across TX — which companies pay providers there.